| COVID-19 Vaccine |
1 |
1 |
| Immunization |
0 |
0.85 |
| Influenza Vaccine |
0 |
0.71 |
| Vaccines |
0 |
0.68 |
| Multiple Sclerosis |
0 |
0.99 |
| COVID-19 |
0 |
0.33 |
| T-Lymphocyte |
0 |
0.32 |
| T-Cell Receptor |
0 |
0.25 |
| COVID-19 Omicron Variant |
0 |
0.21 |
| Disease-Modifying Therapy |
0 |
0.21 |
| Ohio |
0 |
0.21 |
| Immunocompromise |
0 |
0.11 |
| Pandemic |
0 |
0.11 |
| Receptors |
0 |
0.11 |
| Severe Acute Respiratory Syndrome |
0 |
0.11 |
| Tetanus |
0 |
0.11 |
| Acute Respiratory Distress Syndrome |
0 |
0.05 |
| Influenza |
0 |
0.05 |